Navigation Links
Newly Integrated Software Suite From ZS Associates Offers Comprehensive Set of Sales Performance Management Software Solutions
Date:10/8/2008

he firm today has more than 1,000 professionals in 17 offices around the world. It has assisted more than 700 clients in 70 countries. ZS consultants combine deep expertise in sales and marketing with rigorous, fact-based analysis to help business leaders develop and implement effective sales and marketing strategies.

As the largest global consulting firm focused on sales and marketing, ZS Associates has experience across a broad range of industries, including pharmaceuticals, biotechnology, medical products and services, high-tech, telecommunications, transportation, consumer products and financial services. The company's Javelin(TM) Software Suite offers a comprehensive set of tools to address a wide range of sales and marketing challenges.

For more information on ZS Associates, call 1-847-492-3602 or visit http://www.zsassociates.com.

MarketScope Disclaimer

The MarketScope is copyrighted July 30, 2008 by Gartner, Inc. and is reused with permission. The MarketScope is an evaluation of a marketplace at and for a specific time period. It depicts Gartner's analysis of how certain vendors measure against criteria for that marketplace, as defined by Gartner. Gartner does not endorse any vendor, product or service depicted in the MarketScope, and does not advise technology users to select only those vendors with the highest rating. Gartner disclaims all warranties, express or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.


'/>"/>
SOURCE ZS Associates
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications
2. Isis Pharmaceuticals and Thomas, McNerney & Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory Conditions
3. Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ... Major Weapon in the Battle Against Cancer
4. Newly Published EPA RCRA Method 6800 Supports AIT Technology
5. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
6. Augusta Systems Technologies Integrated into Ciscos Newly Launched Safety and Security Platform
7. Cleveland Clinic and Rutgers to Lead Newly Formed Institute for War Wounded
8. Informed Medical Communications Adopts Newly Enhanced Compliance Policy
9. China Biologic Products Begins Operation of its Newly Constructed Plasma Collection Station in Qi He County, Shandong Province
10. Human Trial Results Show Plant Extract Tops Drug at Regulating Blood Sugar Levels; Huge Market Seen for Newly Developed Food Additive Emulin™
11. Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Breakthrough in monitoring tropical deforestation announced in Copenhagen 2Hebrew University, American researchers show 'trigger' to stem cell differentiation 2Pathological gambling may be successfully treated with medications for substance addiction 2HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 1HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 2HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 3Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive 28R 29 13823 1Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive 28R 29 13823 2Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive 28R 29 13823 3Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive 28R 29 13823 4Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive 28R 29 13823 5Service Dogs Help Traumatized Veterans Heal 56119 1Service Dogs Help Traumatized Veterans Heal 56119 2Service Dogs Help Traumatized Veterans Heal 56119 3